Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000914:Antibodies, Viral / Q000032:analysis; D000956:Antigens, Viral / Q000494:pharmacology; D006678:HIV / Q000276:immunology*; D015483:HIV Antibodies; D015488:HIV Antigens; D006801:Humans; D014759:Viral Envelope Proteins / Q000494:pharmacology; D014765:Viral Vaccines / Q000276:immunology*
D000914:Antibodies, Viral; D000956:Antigens, Viral; D015483:HIV Antibodies; D015488:HIV Antigens; D014759:Viral Envelope Proteins; D014765:Viral Vaccines